INCOME TAXES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	$ 49,550,149
Research activities carryforwards	511,949
Period of cumulative changes in ownership considered for limit on operating loss and tax credit carryforwards	3 years
Minimum percentage of cumulative changes in ownership considered for limit on operating loss and tax credit carryforwards (in hundredths)	50.00%
Deferred tax assets [Abstract]
Net operating loss carryforwards	17,657,746	16,549,134
Intangible assets	247,248	305,552
Other	512,286	502,732
Total gross deferred tax assets	18,417,280	17,357,418
Deferred tax liabilities [Abstract]
Property and equipment	72,347	77,839
Total gross deferred tax liabilities	72,347	77,839
Net total of deferred assets and liabilities	18,344,933	17,279,579
Valuation allowance	(18,344,933)	(17,279,579)
Net deferred tax assets	0	0
Increase in valuation allowance	1,065,354	1,225,683
Reconciliation of expected statutory federal income tax rate to actual income tax rate [Abstract]
Expected income tax (benefit) at federal statutory tax rate -35%	(1,137,320)	(1,309,975)
Permanent differences	21,754	16,500
Research tax credits	(15,882)	(8,690)
Amortization of deferred start up costs	0	0
Valuation allowance	1,131,448	1,302,165
Income tax expense	0	0
Federal statutory tax rate (in hundredths)	35.00%
Liability for unrecognized tax benefits	0	0
2021 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	34,248
Research activities carryforwards	0
2023 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	95,666
Research activities carryforwards	0
2024 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	910,800
Research activities carryforwards	13,584
2025 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	1,687,528
Research activities carryforwards	21,563
2026 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	11,950,281
Research activities carryforwards	60,797
2027 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,431,365
Research activities carryforwards	85,052
2028 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	8,824,940
Research activities carryforwards	139,753
2029 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	6,889,761
Research activities carryforwards	81,940
2030 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	5,113,583
Research activities carryforwards	41,096
2031 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,728,626
Research activities carryforwards	43,592
2032 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,695,792
Research activities carryforwards	8,690
2033 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,187,559
Research activities carryforwards	$ 15,882